July 16, 2019 — ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the American Association of Physicists in Medicine (AAPM) for presentation during their 2019 Annual Meeting, July 14-18 in San Antonio, Texas.

Magnetic resonance imaging (MRI)-guided radiotherapy will be highlighted in a number of abstracts and posters throughout the scientific program at AAPM 2019, illustrating the growing interest in this treatment approach. The MRIdian-specific research being presented will cover topics including motion prediction, quality assurance, stereotactic body radiation therapy (SBRT), adaptive therapy and tumor response assessment. These abstracts feature MRIdian experience from institutions such as: 

• Washington University School of Medicine in St. Louis; 

• Henry Ford Health System (HFHS); 

• University of California Los Angeles (UCLA); 

• University of Wisconsin; 

• Loyola University Medical Center, Chicago; 

• University of Miami; 

• Miami Cancer Institute at Baptist Health South Florida; 

• Institute of Health Science at Acibadem University, Istanbul; 

• Amsterdam University Medical Centers; 

• The NewYork-Presbyterian Hospital; 

• UF Health Cancer Center at Orlando Health; 

• Institut Paoli-Calmettes, Marseille; 

• Rigshospitalet Copenhagen; and 

• Heidelberg University Hospital.

Noteworthy MRIdian abstracts featured in AAPM's Scientific Program include:

• Data from an international consortium of 12 MRIdian centers that demonstrated excellent agreement in multi-institutional commissioning data;

• Three presentations that showcase the ability to use functional imaging on a low-field MRI; and

• Research awarded the "Best in Physics (Multi-disciplinary)" designation, which is the first to highlight that quantitative T1 mapping is meaningful and Strategically Acquired Gradient Echo (STAGE) MRI is promising for functional brain cancer imaging at 0.35T.

AAPM attendees can learn more about MRIdian and MRI-Guided Real-time On-table Adaptive Radiotherapy (ROAR) in ViewRay's booth. Presentations will be made in the company's booth throughout the meeting by MRIdian clinical users. Presenters will share their MRIdian experience and highlight topics such as the value of MRI-guided RT, real-time tracking and automated gating, optimal magnetic field strength for RT, adaptive therapy workflows, online quality assurance, program implementation and clinical efficiencies.

The ViewRay booth will also feature demonstrations of the MRIdian System's adaptive workflow, which helps to improve targeting precision and accuracy to deliver higher, and potentially more effective, radiation doses. 

For more information: www.viewray.com

Related Content

VIDEO: Walk Through of the MRI Radiotherapy System at Henry Ford Hospital

VIDEO: MRI-Guided Radiation Therapy Trial for Pancreatic Cancer

VIDEO: Clinical Use of the ViewRay MRIdian Linac System at Henry Ford